FDA Approves Wegovy for Liver Disease, Boosting Novo Nordisk Shares
URGENT UPDATE: Novo Nordisk’s stock is surging following the FDA’s recent approval of Wegovy for treating a specific form of liver disease. This landmark decision, announced on October 10, 2023,…